Lilly, Biolojic to develop antibody therapies for diabetes treatment

Lilly, Biolojic to develop antibody therapies for diabetes treatment

Source: 
Pharmaceutical Business Review
snippet: 

Eli Lilly and Company has signed a research collaboration and license agreement with Biolojic Design to discover and develop therapies for diabetes treatment.